Feb 12, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The LEERINK Partners 7th Annual Global Healthcare Conference in New York, NY on...

Feb 8, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal first quarter ended December 30, 2017. Revenue of $791.1 million increased 7.7%, or 6.7% in constant...

Jan 29, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that holders of the 2.00% Convertible Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012 have the right to surrender their notes for...

More ›


SEC Filings
NASDAQHOLX